Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
1Biotechnica
- Ownership
- Private
- Development stage
- Other
01
Overview
1Biotechnica is an early-stage biotechnology company focused on the discovery and development of novel therapeutic agents for metabolic, inflammatory, and oncological conditions. The company leverages its expertise in medicinal chemistry and molecular biology to target high-value biological pathways, particularly G protein-coupled receptors (GPCRs). Currently, 1Biotechnica's programs are in the pre-clinical stage, with a focus on optimizing lead compounds for improved efficacy and safety profiles. The firm aims to address significant unmet medical needs through innovative drug design and strategic research collaborations.
- Therapeutic areas
- OncologyImmunologyMetabolic Disorders
- Modalities
- Small moleculePeptides
- Industry
- Biotech
Beyond the preview
Go deeper on 1Biotechnica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1Biotechnica.